In this study, we found that serum CEA and tumor grade were potentially associated with uncommon EGFR mutation, whereas no significant correspondence was found in stage and ECOG PS, which had been proved to have independent prognostic value for NSCLC patients in previous studies. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.